Notices. Notice of lawsuit; solicitation of information

2,510 words·~11 min read·/register/2006/04/21/06-3795

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4310-05-M DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on September 12, 2005, Guilford Pharmaceuticals, Inc., 6611 Tributary Street, Baltimore, MD 21224, made application by renewal to the Drug Enforcement Administration

(DEA)to be registered as a bulk manufacturer of Cocaine (9041), a basic class of controlled substance listed in Schedules II. The company plans to manufacture a cocaine derivative to be used in clinical research studies. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, VA 22301; and must be filed no later than June 20, 2006. Dated: April 17, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6-5966 Filed 4-20-06; 8:45 am] BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in Schedule I or II and prior to issuing a regulation under 21 U.S.C. 952(a)(2)(B) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing. Therefore, in accordance with 21 CFR 1301.34(a), this is notice that on August 29, 2005, Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816, made application to the Drug Enforcement Administration

(DEA)to be registered as an importer of the basic classes of controlled substances listed in Schedule II: Drug Schedule Raw Opium

(9600)II Concentrate of Poppy Straw

(9670)II The company plans to import narcotic raw materials in ancillary activities including process development and analytical studies. Any manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances may file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than May 22, 2006. This procedure is to be conducted simultaneously with and independent of the procedures described in 21 CFR 1301.34(b), (c), (d),

(e)and (f). As noted in a previous notice published in the **Federal Register** on September 23, 1975, (40 FR 43745-46), all applicants for registration to import a basic class of any controlled substance listed in Schedule I or II are, and will continue to be required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1301.34(b), (c), (d),

(e)and

(f)are satisfied. Dated: April 17, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6-5967 Filed 4-20-06; 8:45 am] BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated November 18, 2005, and published in the **Federal Register** on November 29, 2005, (70 FR 71558), American Radiolabeled Chemicals, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made application by renewal to the Drug Enforcement Administration

(DEA)to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedules I and II: Drug Schedule Gamma hydroxybutyric acid

(2010)I Dimethyltryptamine

(7435)I Dihydromorphine

(9145)I Amphetamine

(1100)II Methamphetamine

(1105)II Lysergic acid diethylamide

(7315)II Phencyclidine

(7471)II Phenylacetone

(8501)II Cocaine

(9041)II Codeine

(9050)II Oxycodone

(9143)II Hydromorphone

(9150)II Benzoylecgonine

(9180)II Ecgonine

(9180)II Meperidine

(9230)II Metazocine

(9240)II Morphine

(9300)II Thebaine

(9333)II Oxymorphone

(9652)II The company plans to manufacture in bulk, small quantities of the listed controlled substances as radiolabeled compounds. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) Dand determined that the registration of American Radiolabeled Chemicals, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated American Radiolabeled Chemicals, Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: April 17, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6-5961 Filed 4-20-06; 8:45 am] BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated November 18, 2005, and published in the **Federal Register** on November 29, 2005, (70 FR 71558), Chemic Laboratories, Inc., 480 Neponset Street, Building 7C, Canton, Massachusetts 02021, made application by renewal to the Drug Enforcement Administration

(DEA)to be registered as a bulk manufacturer of Cocaine (9041), a basic class of controlled substance listed in Schedules II. The company plans to manufacture small quantities of a cocaine derivative for distribution to its customers for the purpose of research. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Chemic Laboratories, Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Chemic Laboratories, Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. Dated: April 17, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6-5963 Filed 4-20-06; 8:45 am] BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated November 18, 2005, and published in the **Federal Register** on November 29, 2005, (70 FR 71559), Dade Behring Inc., Regulatory Affairs, Quality Systems, 20400 Mariani Avenue, Cupertino, California 95014, made application by renewal to the Drug Enforcement Administration

(DEA)to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedules I and II: Drug Schedule Tetrahydrocannabionols

(7370)I Benzoylecgonine

(9180)II Morphine

(9300)II The company plans to produce the listed controlled substances in bulk to be used in the manufacturer of reagents and drug calibrator/controls for DEA exempt products. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Dade Behring Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Dade Behring Inc., to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: April 17, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6-5962 Filed 4-20-06; 8:45 am] BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated November 18, 2005, and published in the **Federal Register** on November 29, 2005, (70 FR 71559), Dade Behring Inc., 100 GBE Drive, MS514, Post Office Box 6101, Attention: RA/QS, Newark, Delaware 19714-6101, made application by renewal to the Drug Enforcement Administration

(DEA)to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedules I and II: Drug Schedule Tetrahydrocannabionols

(7370)I Benzoylecgonine

(9180)II Morphine

(9300)II The company plans to produce the listed controlled substances in bulk to be used in the manufacturer of reagents and drug calibrator/controls for DEA exempt products. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Dade Behring Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Dade Behring Inc., to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: April 17, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6-5965 Filed 4-20-06; 8:45 am] BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated November 18, 2005, and published in the **Federal Register** on November 29, 2005, (70 FR 71559), ISP, Freetown Fine Chemicals, Inc., 238 South Main Street, Assonet, Massachusetts 02702, made application by renewal to the Drug Enforcement Administration

(DEA)to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedules I and II: Drug Schedule 2,5-Dimethoxyamphetamine

(7396)I Amphetamine

(1100)II Phenylacetone

(8501)II The company plans to manufacturer Phenylacetone to be used in the manufacturer of amphetamine for distribution to its customers. The bulk 2,5-dimethoxyamphetamine will be used for conversion into non-controlled substances. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of ISP, Freetown Fine Chemicals, Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated ISP, Freetown Fine Chemicals, Inc., to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: April 17, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6-5964 Filed 4-20-06; 8:45 am] BILLING CODE 4410-09-P DEPARTMENT OF LABOR Occupational Safety and Health Administration Freedom of Information Act; Notice of Lawsuit AGENCY: Occupational Safety and Health Administration (OSHA), Department of Labor. ACTION: Notice of lawsuit; solicitation of information. SUMMARY: OSHA seeks information about potential objections to public release of sampling data. DATES: Comments must be submitted by the following dates: *Hard copy:* Your comments must be submitted (postmarked or received) by May 22, 2006. *Facsimile and electronic transmission:* Your comments must be received by May 22, 2006. ADDRESSES: You may submit comments by any of the following methods: *Regular mail, express delivery, hand delivery, and messenger service:* Submit your comments and attachments to: Kevin Ropp, Director, OSHA Office of Communications, Room N-3647, U.S. Department of Labor, 200 Constitution Avenue, NW., Washington, DC 20210; telephone

(202)693-1999, (OSHA's TTY number is

(877)889-5627), Office of Communication and Department of Labor hours are: 8:15 a.m. to 4:45 p.m., e.t. *Facsimile:* If your comments are 10 pages or fewer in length, including attachments, you may fax them to Kevin Ropp at

(202)693-1635. *Electronic:* You may submit comments through the Internet at: *http://ecomments.osha.gov* . For submitting comments electronically follow instructions for submitting comments on the OSHA Web page at *http://www.OSHA.gov* . FOR FURTHER INFORMATION CONTACT: Kevin Ropp, Director, OSHA Office of Communications, Room N-3647, U.S. Department of Labor, 200 Constitution Avenue, NW., Washington, DC 20210; telephone:

(202)693-1999 or fax:

(202)693-1635. SUPPLEMENTARY INFORMATION: I. Background This notice pertains to all employers that were subject to air sampling by the Occupational Safety and Health Administration (“OSHA”) from 1979 to June 1, 2005. On November 22, 2005, the Department was sued in the United States District Court for the District of New Jersey under the Freedom of Information Act

(FOIA)to compel the disclosure of all air sampling data that OSHA collected nationwide from 1979 to June 1, 2005. *Adam M. Finkel* v. *United States Department of Labor, Occupational Safety and Health Administration* , No. 3:05-cv-05525-MLC-TJB. This notice is required by 29 CFR 70.26(h). A complete response to this FOIA request would result in the public disclosure of sampling records located at OSHA's Salt Lake City Technical Center, which processes workplace samples taken by OSHA compliance officers during onsite compliance visits. II. Issues for Comment The FOIA request seeks information concerning all samples taken by OSHA from 1979 to June 1, 2005. Information requested for each sample includes the establishment name and address; the identity of the substances sample; the sample type (personal, bulk, area, wipe, etc.); the numerical results of the sample analysis; and other information. OSHA hereby solicits comments from affected employers in order to determine whether public release, in a form that identifies specific employers or workplaces, of sampling data that indicates chemical identities and the use or presence of particular chemicals or substances, would disclose confidential commercial or trade secret information. Signed at Washington, DC this 17th day of April, 2006. Edwin G. Foulke, Jr., Assistant Secretary of Labor. [FR Doc. 06-3795 Filed 4-20-06; 8:45 am]

Connectionstraces to 8

Traces to 8 documents

CFR

U.S. Code

Citation graph

cites case law

Notices

Notice of lawsuit; solicitation of information